124 related articles for article (PubMed ID: 38303229)
1. [Considering Recurrence Prevention Regimen for Colorectal Cancer Patients with Hyperammonemia Caused by Chemotherapy Containing 5-Fluorouracil].
Aomatsu N; Tsujio G; Aomatsu K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1851-1853. PubMed ID: 38303229
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Hyperammonemic Encephalopathy following mFOLFOX6 plus Panitumumab Therapy for Rectal Cancer].
Tsujio G; Muguruma K; Eguchi S; Iseki Y; Miki Y; Yoshii M; Fukuoka T; Tamura T; Shibutani M; Nagahara H; Toyokawa T; Tanaka H; Lee S; Yashiro M; Ohira M
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2073-2075. PubMed ID: 35045497
[TBL] [Abstract][Full Text] [Related]
3. [A Case Altered Consciousness Due to 5-Fluorouracil-Induced Hyperammonemia in a Patient with Recurrent Colorectal Cancer].
Sawazaki S; Numata M; Ju M; Morita J; Komori K; Maezawa Y; Amano S; Aoyama T; Tamagawa H; Sato T; Oshima T; Mushiake H; Yukawa N; Masuda M; Rino Y
Gan To Kagaku Ryoho; 2019 Oct; 46(10):1632-1634. PubMed ID: 31631158
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Disturbance of Consciousness Due to Hyperammonemia during Chemotherapy for Metastasis of Sigmoid Colon Cancer].
Kaizaki R; Inoue T; Eguchi S; Nishiyama T; Nobori C; Kunimoto T; Okazaki Y; Takatsuka S; Tsukamoto T; Nishiguchi Y
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1777-1779. PubMed ID: 33468826
[TBL] [Abstract][Full Text] [Related]
5. Hyperammonemia with impaired consciousness caused by continuous 5-fluorouracil infusion for colorectal cancer: A case report.
Nakamura T; Shibata S; Miyatani Y; Matsubara H
Int J Clin Pharmacol Ther; 2020 Dec; 58(12):727-731. PubMed ID: 32909537
[TBL] [Abstract][Full Text] [Related]
6. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group.
Bond MJG; Bolhuis K; Loosveld OJL; de Groot JWB; Droogendijk H; Helgason HH; Hendriks MP; Klaase JM; Kazemier G; Liem MSL; Rijken AM; Verhoef C; de Wilt JHW; de Jong KP; Gerhards MF; van Amerongen MJ; Engelbrecht MRW; van Lienden KP; Molenaar IQ; de Valk B; Haberkorn BCM; Kerver ED; Erdkamp F; van Alphen RJ; Mathijssen-van Stein D; Komurcu A; Lopez-Yurda M; Swijnenburg RJ; Punt CJA;
Lancet Oncol; 2023 Jul; 24(7):757-771. PubMed ID: 37329889
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia.
Nishikawa Y; Funakoshi T; Horimatsu T; Miyamoto S; Matsubara T; Yanagita M; Nakagawa S; Yonezawa A; Matsubara K; Muto M
Cancer Chemother Pharmacol; 2017 Mar; 79(3):629-633. PubMed ID: 28204913
[TBL] [Abstract][Full Text] [Related]
8. [A Case of Consciousness Disturbance Caused by Hyperammonemia during a mFOLFOX6 Regimen for Metastatic Colon Cancer].
Kagawa Y; Kato T; Naito A; Murakami K; Katsura Y; Ohmura Y; Okishiro M; Takeno A; Egawa C; Takeda Y; Tamura S
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2160-2. PubMed ID: 26805297
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Recurrent Hyperammonemic Encephalopathy during Adjuvant Chemotherapy(Modified FOLFOX6)for Colorectal Cancer].
Yoshino Y; Tamura A; Kagami S; Funahashi K
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1665-1668. PubMed ID: 30449860
[TBL] [Abstract][Full Text] [Related]
10. [Case of Hyperammonemia Induced by High-Dose Fluorouracil].
Hagiwara A; Abe M; Mafune K; Saito M; Kusakabe A
Gan To Kagaku Ryoho; 2019 May; 46(Suppl 1):147-149. PubMed ID: 31189842
[TBL] [Abstract][Full Text] [Related]
11. [A case of 5-fluorouracil-induced hyperammmonia after chemotherapy for metastatic colon cancer].
Nakamura M; Kobashikawa K; Tamura J; Takaki R; Ohshiro M; Matayoshi R; Hirata T; Kinjyo F; Fujita J
Nihon Shokakibyo Gakkai Zasshi; 2009 Dec; 106(12):1744-50. PubMed ID: 19966516
[TBL] [Abstract][Full Text] [Related]
12. [A case of hyperammonemic encephalopathy related to 5-FU in an aged patient with recurrent colon cancer treated with FOLFIRI therapy].
Okamura T; Kawachi Y; Nikkuni K; Nishimura A; Makino S; Kawahara M; Kitami C; Hashimoto Y
Gan To Kagaku Ryoho; 2013 May; 40(5):671-3. PubMed ID: 23863598
[TBL] [Abstract][Full Text] [Related]
13. [A case of hyperammonemia with encephalopathy related to FOLFIRI chemotherapy for advanced colon cancer].
Toyokawa A; Nakajima T; Inui K; Yamashita H; Gon H; Kanemitsu K; Tanaka K; Tsukamoto T; Hamabe Y; Ishida T
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1167-9. PubMed ID: 19620810
[TBL] [Abstract][Full Text] [Related]
14. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Cremolini C; Antoniotti C; Rossini D; Lonardi S; Loupakis F; Pietrantonio F; Bordonaro R; Latiano TP; Tamburini E; Santini D; Passardi A; Marmorino F; Grande R; Aprile G; Zaniboni A; Murgioni S; Granetto C; Buonadonna A; Moretto R; Corallo S; Cordio S; Antonuzzo L; Tomasello G; Masi G; Ronzoni M; Di Donato S; Carlomagno C; Clavarezza M; Ritorto G; Mambrini A; Roselli M; Cupini S; Mammoliti S; Fenocchio E; Corgna E; Zagonel V; Fontanini G; Ugolini C; Boni L; Falcone A;
Lancet Oncol; 2020 Apr; 21(4):497-507. PubMed ID: 32164906
[TBL] [Abstract][Full Text] [Related]
15. mFOLFOX6 Plus Panitumumab Versus 5-FU/LV Plus Panitumumab After Six Cycles of Frontline mFOLFOX6 Plus Panitumumab: A Randomized Phase II Study of Patients With Unresectable or Advanced/Recurrent, RAS Wild-type Colorectal Carcinoma (SAPPHIRE)-Study Design and Rationale.
Nagata N; Mishima H; Kurosawa S; Oba K; Sakamoto J
Clin Colorectal Cancer; 2017 Jun; 16(2):154-157.e1. PubMed ID: 28284575
[TBL] [Abstract][Full Text] [Related]
16. [Hyperammonemia with Disturbance of Consciousness during 5-FU plus Nedaplatin Therapy for Esophageal Cancer-A Case Report].
Okada T; Hirakawa T; Morimoto J; Tanaka H; Miyamoto H; Tsujio G; Kurihara S; Matsutani S; Nagashima D; Hirata K; Iwauchi T; Yamagata S; Uchima Y; Takeuchi K
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1839-1841. PubMed ID: 33468846
[TBL] [Abstract][Full Text] [Related]
17. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.
Cremolini C; Loupakis F; Antoniotti C; Lupi C; Sensi E; Lonardi S; Mezi S; Tomasello G; Ronzoni M; Zaniboni A; Tonini G; Carlomagno C; Allegrini G; Chiara S; D'Amico M; Granetto C; Cazzaniga M; Boni L; Fontanini G; Falcone A
Lancet Oncol; 2015 Oct; 16(13):1306-15. PubMed ID: 26338525
[TBL] [Abstract][Full Text] [Related]
18. Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in
Modest DP; Karthaus M; Fruehauf S; Graeven U; Müller L; König AO; Fischer von Weikersthal L; Caca K; Kretzschmar A; Goekkurt E; Haas S; Kurreck A; Stahler A; Held S; Jarosch A; Horst D; Reinacher-Schick A; Kasper S; Heinemann V; Stintzing S; Trarbach T
J Clin Oncol; 2022 Jan; 40(1):72-82. PubMed ID: 34533973
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Severe Hyperammonemic Encephalopathy in a Dialysis Patient Following mFOLFOX6 Therapy].
Furuyama T; Enjoji M; Yamato M; Kondo I; Hinokida M; Tatsutomi Y; Nakazawa K; Nagayama K; Ushirokoji Y
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1676-1678. PubMed ID: 35046294
[TBL] [Abstract][Full Text] [Related]
20. [A Case of Metastatic Colorectal Cancer with Hyperammonemic Encephalopathy Induced by mFOLFOX6 and SOX Therapy].
Murase H; Oono R; Yoshida T; Suzuki Y; Hayashi K; Nishino M; Irie T; Suzuki Y; Higuchi K; Baba H; Takahashi H; Yoshinouchi S; Ueda Y; Enjoji M; Obata M
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1780-1782. PubMed ID: 33468827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
